TAU makes breakthrough in drug delivery to treat inflammatory bowel disease
To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and ...
Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic ...
KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...
dermatologyadvisor6 天
Drug Survival in Psoriasis Affected by Age at Initiation, Biologic Therapy Type
Age at initiation of treatment and the type of biologic therapy prescribed effect the rate of drug survival among patients with psoriasis.